Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03850366
Title HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Henry Ford Health System
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.